• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of April 24, 2013

  • Print
  • Share
  • E-mail

Product Detail

Product Description Source Plasma
Recall Number B-0933-13
Classification Class II
Code Info 05IMOA0697; 05IMOA0914; 05IMOA1311; 05IMOA1588; 05IMOA2057; 05IMOA2312; 05IMOA2669; 05IMOA2996; 05IMOA3358; 05IMOA3582; 05IMOA4007; 05IMOA4251; 05IMOA4655; 05IMOA4877; 05IMOA5269; 05IMOA5536; 05IMOA5997; 05IMOA6209; 05IMOA6648; 05IMOA6944; 05IMOA7372; 05IMOA7650; 05IMOA8410; 05IMOA9490; 05IMOA9751; 05IMOB1163; 05IMOB2262; 05IMOB2549; 05IMOB3013; 05IMOB3290; 05IMOB3698; 05IMOB3976; 05IMOB4378; 05IMOB4683
Product Distributed Qty 34 units
Reason For Recall Blood products, collected from a donor who received a piercing within 12 months of the donation, were distributed.

Event Detail

Event Id 40646
Product Type Biologics
Status Terminated
Recalling Firm BioLife Plasma Services L.P.
City Independence
State MO
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2005-07-26
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern CA